Volume 24 Issue 4
Apr.  2026
Turn off MathJax
Article Contents
GUO Lijuan, MA Fangxu, BAO Jie, WANG Shuang, LI Yi. A model study of biomarkers combined with lung function to predict the risk of acute exacerbations of COPD[J]. Chinese Journal of General Practice, 2026, 24(4): 589-592. doi: 10.16766/j.cnki.issn.1674-4152.004446
Citation: GUO Lijuan, MA Fangxu, BAO Jie, WANG Shuang, LI Yi. A model study of biomarkers combined with lung function to predict the risk of acute exacerbations of COPD[J]. Chinese Journal of General Practice, 2026, 24(4): 589-592. doi: 10.16766/j.cnki.issn.1674-4152.004446

A model study of biomarkers combined with lung function to predict the risk of acute exacerbations of COPD

doi: 10.16766/j.cnki.issn.1674-4152.004446
Funds:

 20242171

  • Received Date: 2025-12-11
  •   Objective  To investigate the value of a combined lung function index model constructed from soluble cancer suppressor factor 2 (sST2), chitinase protein 40 (YKL-40), interleukin-10 (IL-10), and pulmonary surfactant D (SP-D) in early risk assessment of chronic obstructive pulmonary disease (COPD) acute exacerbations.  Methods  A total of 120 COPD patients admitted at Hebei Provincial Chest Hospital between January 2023 and December 2024 were selected as subjects, and divided into stable phase group (60 cases) and acute exacerbation phase group (60 cases) based on whether they experienced acute exacerbations. All patients ' serum levels of sST2, YKL-40, IL-10, and SP-D were measured, along with pulmonary function tests. Multivariate logistic regression was used to identify independent risk factors for COPD acute exacerbations, and a combined prediction model was established. The predictive efficacy of each indicator and the combined model was evaluated using receiver-operating characteristic (ROC) curves.  Results  Patients in the acute exacerbation group showed significantly higher serum levels of sST2, YKL-40, and SP-D compared to the stable phase group (P < 0.05), while IL-10 and FEV1%pred were markedly lower (P < 0.05). Multivariate logistic regression analysis demonstrated that all four biomarkers-sST2, YKL-40, IL-10, SP-D, and FEV1% pred-were independent predictors of COPD acute exacerbations (P < 0.05). The combined predictive model achieved an area under the curve (AUC) of 0.923 (95% CI: 0.881-0.965), with a sensitivity of 86.7% and specificity of 88.3%, demonstrating superior predictive performance compared to single biomarkers.  Conclusion  The integrated pulmonary function biomarker model combining sST2, YKL-40, IL-10, SP-D provides reliable prediction for COPD acute exacerbations, offering valuable insights for early risk assessment and clinical intervention guidance.

     

  • loading
  • [1]
    陈典, 隆寰宇, 张丛溪, 等. 2025年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2025, 28(16): 1937-1949.

    CHEN D, LONG H Y, ZHANG C X, 等. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2025 report[J]. Chinese General Practice, 2025, 28(16): 1937-1949.
    [2]
    周晓苹, 方荣华. 全科病房慢性阻塞性肺疾病患者焦虑抑郁状况调查及影响因素分析[J]. 中华全科医学, 2022, 20(6): 1003-1006. doi: 10.16766/j.cnki.issn.1674-4152.002510

    ZHOU X P, FANG R H. Investigation and analysis of factors affecting anxiety and depression in patients with chronic obstructive pulmonary disease in general wards[J]. Chinese Journal of General Practice, 2022, 20(6): 1003-1006. doi: 10.16766/j.cnki.issn.1674-4152.002510
    [3]
    李庆云, 孙娴雯. 慢性阻塞性肺疾病稳定期管理的几个新视点: 2021版GOLD指南解读[J]. 诊断学理论与实践, 2021, 20(1): 43-47.

    LI Q Y, SUN X W. Several new perspectives on the management of stable chronic obstructive pulmonary disease: interpretation of the 2021 GOLD guideline[J]. Diagnostics Theory and Practice, 2021, 20(1): 43-47.
    [4]
    王海静, 李静, 王永红, 等. 慢性阻塞性肺疾病患者外周血核苷酸结合寡聚化结构域样受体蛋白3水平与肺功能、病情程度和预后的关系[J]. 新乡医学院学报, 2022, 39(9): 847-850.

    WANG H J, LI J, WANG Y H, et al. Relationship between peripheral blood NLRP3 level and pulmonary function, disease severity and prognosis in patients with chronic obstructive pulmonary disease[J]. Journal of Xinxiang Medical University, 2022, 39(9): 847-850.
    [5]
    QUOC Q L, CAO T B T, MOON J Y, et al. Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma[J]. Allergol Int, 2024, 73(1): 81-93. doi: 10.1016/j.alit.2023.06.004
    [6]
    LI C L, LIU S F. Exploring molecular mechanisms and biomarkers in COPD: an overview of current advancements and perspectives[J]. Int J Mol Sci, 2024, 25(13): 7347. DOI: 10.3390/ijms25137347.
    [7]
    BELOV V A, KARPOVA E P, ASMANOV A I, et al. Treatment of chronic tonsillitis: a personalized approach to prevent metatonsillar complications[J]. Pharmateca, 2025, 32(7): 45-52.
    [8]
    SHAMIM A, ABDUL AZIZ M, SAEED F, et al. Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity[J]. Front Immunol, 2024, 15: 1491175. DOI: 10.3389/fimmu.2024.1491175.
    [9]
    AHMED M, ISLAM M S, SULTANA S, et al. Association of Chlamydia trachomatis infection with tubal occlusion in primary infertile women: A cross-sectional study using hysterosalpingography[J]. J Obstet Gynaecol Res, 2024, 50(8): 2891-2898.
    [10]
    SPRUIT M A, SINGH S J, GARVEY C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation[J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64. doi: 10.1164/rccm.201309-1634ST
    [11]
    URBAN M H, STOJKOVIC S, DEMYANETS S, et al. Soluble ST2 and all-cause mortality in patients with chronic obstructive pulmonary disease: a 10-year cohort study[J]. J Clin Med, 2021, 11(1): 56. DOI: 10.3390/jcm11010056.
    [12]
    POPETIU R O, DONATH-MIKLOS I, BORTA S M, et al. Serum YKL-40 levels, leukocyte profiles, and acute exacerbations of advanced COPD[J]. J Clin Med, 2023. DOI: 10.3390/jcm12186106.
    [13]
    PASE M P, HIMALI J J, PUERTA R, et al. Association of plasma YKL-40 with MRI, CSF, and cognitive markers of brain health and dementia[J]. Neurology, 2024, 102(4): e208075. DOI: 10.1212/WNL.0000000000208075.
    [14]
    ZHANG J, CHEN F, WAN Y, et al. Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease[J]. Chin Med J Pulmon Crit Care Med, 2023, 1(2): 102-107. doi: 10.1016/j.pccm.2023.04.004
    [15]
    QIAN Y, CAI C T, SUN M Q, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: a review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723. doi: 10.2147/COPD.S433183
    [16]
    ZHANG C, LING W, PAN H, et al. Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China[J]. Eur J Med Res, 2025, 30(1): 773. doi: 10.1186/s40001-025-03042-z
    [17]
    FAN J, FANG L W, CONG S, et al. Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study[J]. Lancet Reg Health West Pac, 2024, 44: 100984. DOI: 10.1016/j.lanwpc.2023.100984.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Article Metrics

    Article views (18) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return